End-of-life cost for lung cancer patients in Greece: a hospital-based retrospective study
- 1 March 2021
- journal article
- research article
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 10 (4), 315-324
- https://doi.org/10.2217/cer-2020-0167
Abstract
Objective: The aim of the present study was to estimate the cost of treating patients with lung cancer at their end-of-life (EOL) phase of care in Greece. Materials & methods: A hospital-based retrospective study was conducted in the Oncology Unit of ‘Sotiria’ Hospital, in Athens, Greece. All lung cancer patients who died between 1 January 2015 and 31 December 2018 with at least 6 months follow-up were enrolled in the study. Healthcare resource utilization data, including inpatient and outpatient ones, during the last 6 months before death was extracted from a registry kept in the unit. This data were combined with the corresponding local unit costs to calculate the 6, 3 and 1-month EOL cost in €2019 values. Results: A total of 122 patients met the inclusion criteria. The mean (standard deviation) age at diagnosis was 67.8 (8.9) years with 78.7% of patients being male and 55.0% diagnosed at stage IV. About 52.5% of patients had been diagnosed with adenocarcinoma, 28.7% with squamous non-small-cell lung cancer types and 18.9% with small-cell-lung cancer. The median overall survival of these patients was 10.8 months. During the EOL periods, the mean cost/patient in the last 6, 3 and 1 month were €7665, €3351 and €1009, respectively. Pharmaceutical cost was the key driver of the total cost (75% of the total 6-month) followed by radiation therapy (16.2%). The median EOL 6-month cost was marginally statistically significantly higher among patients with adenocarcinoma (€9031) compared with squamous (€6606) and to small-cell-lung cancer (€5474). Conclusion: The findings of the present study indicate that lung cancer treatment incurs high costs in Greece, mainly attributed to pharmaceutical expenses, even at the EOL phase.Keywords
This publication has 22 references indexed in Scilit:
- Health Care Costs for Patients With Cancer at the End of LifeJournal of Oncology Practice, 2012
- American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for OncologyJournal of Clinical Oncology, 2012
- End of life in cancer patients: drugs or words?Annals of Oncology, 2010
- Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement AdjustmentJAMA, 2008
- Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?Journal of Clinical Oncology, 2008
- Cost of Care for Elderly Cancer Patients in the United StatesJNCI Journal of the National Cancer Institute, 2008
- Costs of cancer care in the USA: a descriptive reviewNature Clinical Practice Oncology, 2007
- A comparison of multivariable regression models to analyse cost dataJournal of Evaluation in Clinical Practice, 2006
- The economic burden of lung cancer and the associated costs of treatment failure in the United StatesLung Cancer, 2005
- Treatment pathways, resource use and costs in the management of small cell lung cancerThorax, 2001